The androgen receptor gene polymorphism and clinical picture of androgen deficiency syndrome during aging male of men's population in Wroclaw;Polimorfizm genu receptora androgenowego a obraz kliniczny zespołu niedoboru androgenów w procesie starzenia siȩ populacji mȩzczyzn wrocławskich

Endokrynologia Polska

Volumn 60, Issue 5, 2009, Pages 370-378

  Trzmiel Bira, Anna ^a   Filus, Alicja ^a   Kuliczkowska Płaksej, Justyna ^a   Łaczmański, Łukasz ^a   Mȩdraś, Marek ^a,b  

^a Katedra i Klinika Endokrynologii   (Poland)

^b UNIVERSITY SCHOOL OF PHYSICAL EDUCATION   (Poland)

Author keywords

Aging male; Androgen receptor; Andropausal syndrome; CAC repeat; Heinemann scale; Polymorphism

Indexed keywords

ANDROGEN RECEPTOR;

ADULT; AGED; AGING; ANDROGEN DEFICIENCY; ANDROPAUSE; ARTICLE; BODY MASS; CLINICAL FEATURE; DISEASE SEVERITY; DNA POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MALE; POLAND; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; QUESTIONNAIRE; RECEPTOR GENE; SEXUAL DYSFUNCTION; TRINUCLEOTIDE REPEAT;

AGED; AGING; ANDROGEN-INSENSITIVITY SYNDROME; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POLAND; POLYMORPHISM, GENETIC; RECEPTORS, ANDROGEN; TRINUCLEOTIDE REPEATS;

EID: 72449124736     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Zitzmann M, Gromoll J, Nieschlag E. The androgen receptor CAG repeat polymorphism. The Authors Journal Compilation, Blackwell Publishing Ltd. Adrologia 2005; 37: 216.
2. Canale D, Caglieresi C, Moschini C i wsp. Androgen receptor polymorphism (CAG repeats) and androgenicity. Clinical Endocrinology 2005; 63: 356-361.
3. Lubahn DB, Joseph DR, Sullivan PM i wsp. Cloning of the human androgen receptor complementary DNA and localization to the X chromosome. Science 1988; 240: 327-330.
4. Morales A, Lunenfeld B. International Society for the Study of the Aging Male. Standards, guidelines and recommendations of the International Society for the Study of the Aging Male (ISSAM). Investigation, treatment and monitoring of late-onset hypogonadism in males. Aging Male 2002; 5: 74-86.
5. Burns-Cox N, Gingell C. The andropause: fact or fiction? Postgrad Med J 1997; 73: 553-556.
6. Daig I, Heinemann L, Kim S i wsp. The Aging Male's Symptom (AMS) scale: revive of its methodological characteristics. Health and Quality of Life Outcomes 2003; 1:77.
7. Laskosz A. Winien testosteron? Sprawy nauki. Biuletyn Ministra Nauki i Szkolnictwa Wyższego 2004; 3.
8. International Society For The Study Of The Aging Male, www.issam.ch.
9. Shibayama Y, Higashi T, Shimada K i wsp. Simultaneous determination of salivary testosterone and dehydroepiandrosterone using LC-MS/MS: Method development and evaluation of applicability for diagnosis and medication for late-onset hypogonadism. J Chromatogr B Analyt Technol Biomed Life Sci 2009; 877: 2615-2623.
10. Härkönen K, Huhtaniemi I, Mäkinen J i wsp. The polymorphic androgen receptor gene CAG repeat, pituitary-testicular function and andropausal symptoms in ageing men. Int J Androl 2003; 26: 187-194. (Pubitemid 36718211)
11. Seidman SN, Araujo SB, Roose SP i wsp. Testosterone level, androgen receptor polymorphism, and depressive symptoms in middle-aged men. Biol Psychiatry 2001; 50: 371-376.